148 related articles for article (PubMed ID: 35282706)
1. Neurofibromatosis-associated Gastrointestinal Stromal Tumor Causing Small Bowel Obstruction.
Schaeffer HD; Griffiths RL; Factor MS
Am Surg; 2022 Jul; 88(7):1541-1542. PubMed ID: 35282706
[TBL] [Abstract][Full Text] [Related]
2. Jejunal gastrointestinal stromal tumor that developed in a patient with neurofibromatosis type 1: a case report.
Nagano H; Ohyama S; Sato A; Igarashi J; Yamamoto T; Kadoya M; Kobayashi M
Diagn Pathol; 2023 Oct; 18(1):110. PubMed ID: 37789344
[TBL] [Abstract][Full Text] [Related]
3. Recurrent hematochezia secondary to gastrointestinal stromal tumors (GISTs) in neurofibromatosis type one.
Kupec JT; Williams HJ; Roorda AK; Goebel SU
W V Med J; 2011; 107(4):16-9. PubMed ID: 21902100
[TBL] [Abstract][Full Text] [Related]
4. Rectal carcinoma and multiple gastrointestinal stromal tumors (GIST) of the small intestine in a patient with neurofibromatosis type 1: a case report.
Hakozaki Y; Sameshima S; Tatsuoka T; Okuyama T; Yamagata Y; Noie T; Oya M; Fujii A; Ueda Y; Shimura C; Katagiri K
World J Surg Oncol; 2017 Aug; 15(1):160. PubMed ID: 28835241
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q.
Yamamoto H; Tobo T; Nakamori M; Imamura M; Kojima A; Oda Y; Nakamura N; Takahira T; Yao T; Tsuneyoshi M
J Cancer Res Clin Oncol; 2009 Jun; 135(6):791-8. PubMed ID: 19020900
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen's disease).
Takazawa Y; Sakurai S; Sakuma Y; Ikeda T; Yamaguchi J; Hashizume Y; Yokoyama S; Motegi A; Fukayama M
Am J Surg Pathol; 2005 Jun; 29(6):755-63. PubMed ID: 15897742
[TBL] [Abstract][Full Text] [Related]
7. Multiple gastrointestinal stromal tumors in neurofibromatosis type 1: report of a case.
Hirashima K; Takamori H; Hirota M; Tanaka H; Ichihara A; Sakamoto Y; Ikuta Y; Karashima R; Watanabe M; Iyama K; Baba H
Surg Today; 2009; 39(11):979-83. PubMed ID: 19882321
[TBL] [Abstract][Full Text] [Related]
8. [A case of multiple gastrointestinal stromal tumors of the small intestine associated with von Recklinghausen disease].
Nakamura S; Koyama F; Nakagawa T; Uchimoto K; Otsuki K; Ueda T; Nishigori N; Fujii H; Nakajima Y; Enomoto Y; Nonomura A
Nihon Shokakibyo Gakkai Zasshi; 2011 Jul; 108(7):1222-30. PubMed ID: 21737974
[TBL] [Abstract][Full Text] [Related]
9. [Simultaneous occurrence of an ampullary neuroendocrine tumor and multiple duodenal/jejunal gastrointestinal stromal tumors in a patient with neurofibromatosis type 1].
Kitajima R; Morita Y; Furuhashi S; Kiuchi R; Takeda M; Kikuchi H; Watanabe F; Sugimoto K; Sakaguchi T; Takeuchi H
Nihon Shokakibyo Gakkai Zasshi; 2019; 116(7):583-591. PubMed ID: 31292320
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome.
Søreide K; Sandvik OM; Søreide JA; Gudlaugsson E; Mangseth K; Haugland HK
Clin Transl Oncol; 2012 Aug; 14(8):619-29. PubMed ID: 22855146
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
Miettinen M; Lasota J
Arch Pathol Lab Med; 2006 Oct; 130(10):1466-78. PubMed ID: 17090188
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.
Lasota J; Miettinen M
Histopathology; 2008 Sep; 53(3):245-66. PubMed ID: 18312355
[TBL] [Abstract][Full Text] [Related]
13. Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome.
Gasparotto D; Rossi S; Polano M; Tamborini E; Lorenzetto E; Sbaraglia M; Mondello A; Massani M; Lamon S; Bracci R; Mandolesi A; Frate E; Stanzial F; Agaj J; Mazzoleni G; Pilotti S; Gronchi A; Dei Tos AP; Maestro R
Clin Cancer Res; 2017 Jan; 23(1):273-282. PubMed ID: 27390349
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal stromal tumors in Japanese patients with neurofibromatosis type I.
Nishida T; Tsujimoto M; Takahashi T; Hirota S; Blay JY; Wataya-Kaneda M
J Gastroenterol; 2016 Jun; 51(6):571-8. PubMed ID: 26511941
[TBL] [Abstract][Full Text] [Related]
15. [Multiple gastrointestinal stromal tumors in neurofibromatosis type 1].
Zachäus M; Plötner A; Weimann A; Ruf B
Med Klin (Munich); 2007 Feb; 102(2):163-7. PubMed ID: 17323024
[TBL] [Abstract][Full Text] [Related]
16. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs).
Lasota J; Miettinen M
Semin Diagn Pathol; 2006 May; 23(2):91-102. PubMed ID: 17193822
[TBL] [Abstract][Full Text] [Related]
17. Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview.
Farag S; van der Kolk LE; van Boven HH; van Akkooi ACJ; Beets GL; Wilmink JW; Steeghs N
Fam Cancer; 2018 Apr; 17(2):247-253. PubMed ID: 28710566
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients.
Maertens O; Prenen H; Debiec-Rychter M; Wozniak A; Sciot R; Pauwels P; De Wever I; Vermeesch JR; de Raedt T; De Paepe A; Speleman F; van Oosterom A; Messiaen L; Legius E
Hum Mol Genet; 2006 Mar; 15(6):1015-23. PubMed ID: 16461335
[TBL] [Abstract][Full Text] [Related]
19. Familial gastrointestinal stromal tumors, lentigines, and café-au-lait macules associated with germline c-kit mutation treated with imatinib.
Gupta D; Chandrashekar L; Larizza L; Colombo EA; Fontana L; Gervasini C; Thappa DM; Rajappa M; Rajendiran KS; Sreenath GS; Kate V
Int J Dermatol; 2017 Feb; 56(2):195-201. PubMed ID: 28074523
[TBL] [Abstract][Full Text] [Related]
20. Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.
Joensuu H; Wardelmann E; Sihto H; Eriksson M; Sundby Hall K; Reichardt A; Hartmann JT; Pink D; Cameron S; Hohenberger P; Al-Batran SE; Schlemmer M; Bauer S; Nilsson B; Kallio R; Junnila J; Vehtari A; Reichardt P
JAMA Oncol; 2017 May; 3(5):602-609. PubMed ID: 28334365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
